Home/Virostatics/Franco Lori, MD, PhD
FL

Franco Lori, MD, PhD

CEO / Founder

Virostatics

Therapeutic Areas

Virostatics Pipeline

DrugIndicationPhase
MyrtleciclibBroad spectrum cancers (e.g., mesothelioma, metastatic breast cancer, lymphoma)Pre-clinical
VS2-370Aggressive tumors (breast, lung, pancreas, hemato-oncology)Pre-clinical